Peer Review History
| Original SubmissionNovember 21, 2025 |
|---|
|
PLOS One Dear Dr. Ahmed, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Dear Authors, Please carefully read all the comments provided by the reviewers and address them accordingly, making the necessary changes in the revised manuscript. Best regards and keep well ============================== Please submit your revised manuscript by Jan 23 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mohmed Isaqali Karobari, BDS, MScD.Endo, Ph.D. Endo, FDS, FPFA, FICD, MFDS Academic Editor PLOS One Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 3. Thank you for stating the following financial disclosure: South African Medical Research Council Self-Initiated Research Fun At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please delete it from any other section. 5. Please ensure that you refer to Figure 1 in your text as, if accepted, production will need this reference to link the reader to the figure. 6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Additional Editor Comments: Dear Authors, Please carefully read all the comments provided by the reviewers and address them accordingly, making the necessary changes in the revised manuscript. Best regards and keep well [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: No Reviewer #2: Yes Reviewer #3: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No Reviewer #2: Yes Reviewer #3: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: No ********** Reviewer #1: Overall Assessment This study provides valuable insight into the knowledge, attitudes, and practices (KAP) related to antibiotic prescribing and AMR among dental clinical teachers in South Africa. The topic is highly relevant, aligns with global antimicrobial stewardship priorities, and fits well within PLOS ONE’s scope. The manuscript is generally well-structured and presents clear results. However, several methodological, analytical, and interpretational issues require clarification before the manuscript can be considered for publication. Major Comments 1. Methodology Requires Further Clarification The sampling method is clearly described, but justification for using convenience sampling should be added, including its limitations. Provide more details on questionnaire validation, including: Specific changes made after the pilot study Reliability statistics, if available Please clarify if the questionnaire was adapted from validated tools or fully developed by the authors. 2. Statistical Analysis Section Needs Strengthening Although descriptive statistics and chi-square tests are mentioned, no statistical test results (p-values, test statistics, effect sizes) are presented in the Results. The authors must: Add p-values for associations examined. Indicate which variables showed statistically significant relationships. Provide a brief interpretation of each. 3. Results Section Should Be More Analytical Currently, results are descriptive. To enhance scientific value: Include comparative analysis (e.g., years of experience vs. prescribing behaviour). Present findings from chi-square analyses. If no statistically significant relationships were found, state this explicitly. 4. Discussion Requires Deeper Critical Interpretation The discussion is informative but: It should integrate statistical associations (once added). The issue of clindamycin overuse must be expanded with discussion of: Adverse outcomes International stewardship recommendations Consider adding regional comparisons (Africa) in addition to global literature. 5. Limitations Section Needs Expansion Include: Sampling bias from convenience sampling Self-report bias Single-institution limitations Potential non-responder bias 6. Language and Consistency The manuscript is well written but requires: Minor grammatical refinement Consistency in terminology (e.g., “antibiotic prescribing patterns” vs “prescribing practices”) Minor Comments Ensure all acronyms are spelled out at first mention. Add citations for WHO AWaRe, national guideline documents, and recent AMS literature (optional but recommended). Figure 1 should include axis labels and clearer formatting. Ensure tables follow PLOS ONE formatting guidelines. Reviewer #2: The manuscript addresses an important and interesting topic aligning with global public health priorities. 1-Although the manuscript includes a Limitations section, these aspects should be more acknowledged in the Discussion, particularly: the single-institution sample limits generalizability, convenience sampling, and self-reported prescribing practices. 2-Please provide more discussion on the high dependence on clindamycin as the penicillin alternative. And whether this aligns with the emerging guidelines for antibiotics ? 3-Certain results are reported in both tables and text, leading to unnecessary repetition. 4-Minor typographical inconsistencies are present. Reviewer #3: Thanks for this interesting paper. The power of this paper is its focus on the clinical tutors who influence undergraduate dentists when taking their first steps with patient management. This message is included in your manuscript but should be shining through even more strongly than at present - including in the abstract. And this is a general feature of your manuscript - everything seems to be included but it's not just easy for the audience to find the highlights. My major suggestion is to use the CROSS reporting guideline for survey studies. Abstract - misses some really important information - as per the point above - and in the methods section (e.g. when was this survey undertaken and in which dental school) - and doesn't make efficient use of word count e.g. by repeating points between the results (last line) and conclusion (first line) Introduction - is too long so looses the power of its key points Methods & results - ensure you cover all the points from the CROSS guideline. Discussion - as per comments on the introduction. Much of the first three paragraphs would fit better in the abstract and/or introduction. In the third paragraph it's unclear why so much emphasis is placed on awareness of the WHO Global Action Plan. Clinical teachers certainly need to be aware of how it is has been translated into their context, but the need for awareness of the policy document seems curious. I have not gone through the discussion in detail because it really needs a significant redraft. When doing that, please remember to provide the reader with more information about key papers - for example in which countries were the studies by Sutej and by Hirayama undertaken? And in the next paragraph - it leaves the reader hanging. You need to provide more detail about how the cited studies vary rather than just citing 3 studies. Good luck with the redraft. This will be an important addition to the literature, but it's not ready for publication yet. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Bassam Abdul Rasool Hassan Reviewer #2: No Reviewer #3: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 1 |
|
Dear Dr. Ahmed, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 27 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Mohmed Isaqali Karobari, BDS, MScD.Endo, Ph.D. Endo, FDS, FPFA, FICD, MFDS Academic Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Dear Authors, Please carefully read all the reviewers' comments and address them accordingly, making the necessary changes in the revised manuscript. Best regards and keep well [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: (No Response) Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: (No Response) Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: (No Response) Reviewer #2: Yes ********** Reviewer #1: (No Response) Reviewer #2: • The revised manuscript has been improved. • Please ensure that the "perceived knowledge" vs. "objective knowledge" distinction is clear in the introduction, as the study relies on self-reported data • Please provide consistency in terminology between "antibiotic prescribing patterns" and "prescribing practices". ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Bassam Abdul Rasool Hassan Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Antibiotic Prescribing and Antimicrobial Resistance: An Evaluation of Clinical Teachers' Knowledge, Attitude and Practices at a South African Dental School PONE-D-25-62403R2 Dear Dr. Ahmed, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Mohmed Isaqali Karobari, BDS, MScD.Endo, Ph.D. Endo, FDS, FPFA, FICD, MFDS Academic Editor PLOS One Additional Editor Comments (optional): Dear Authors, The authors have addressed all the reviewers' comments and suggestions, and the manuscript has undergone significant improvement. I would like to congratulate the authors and wish them all the very best in their future endeavours. Best regards and keep well. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: (No Response) Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: (No Response) Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: (No Response) Reviewer #2: Yes ********** Reviewer #1: (No Response) Reviewer #2: The authors have addressed all the comments and suggestions, which has significantly enhanced the clarity, depth, and overall quality of the revised manuscript. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Bassam Abdul Rasool Hassan Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-62403R2 PLOS One Dear Dr. Ahmed, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof Dr. Mohmed Isaqali Karobari Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .